MICONAZOLE 3 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Miconazole 3, and when can generic versions of Miconazole 3 launch?
Miconazole 3 is a drug marketed by Sun Pharma Canada and Perrigo and is included in two NDAs.
The generic ingredient in MICONAZOLE 3 is miconazole nitrate. There are twenty-eight drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the miconazole nitrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Miconazole 3
A generic version of MICONAZOLE 3 was approved as miconazole nitrate by ACTAVIS PHARMA on November 19th, 1993.
US Patents and Regulatory Information for MICONAZOLE 3
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma Canada | MICONAZOLE 3 | miconazole nitrate | CREAM;VAGINAL | 076773-001 | Mar 2, 2005 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Perrigo | MICONAZOLE 3 COMBINATION PACK | miconazole nitrate | CREAM;TOPICAL, VAGINAL | 076357-001 | Mar 30, 2004 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
